| ACID CONCENTRATE 2156 (3.21 G) | 02239491 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE 2182 (1.61 G) | 02210835 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE A1221 (3.48 G) | 02254344 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1222 (6.86 G) | 02254336 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1223 (3.48 G) | 02254328 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1224 (3.48 G) | 02254301 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1225 (6.86 G) | 02254298 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1226 (4.57 G) | 02254255 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1227 (4.57 G) | 02254247 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1228 (1.61 G) | 02533774 | Marketed | Chief Medical Supplies Ltd | Jan 2023 |
| ACID CONCENTRATE A1230 (6.86 G) | 02254085 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1231 (6.86 G) | 02533855 | Marketed | Chief Medical Supplies Ltd | Aug 2023 |
| ACID CONCENTRATE A1241 (6.86 G) | 02533782 | Marketed | Chief Medical Supplies Ltd | Feb 2023 |
| ACID CONCENTRATE A1242 (6.86 G) | 02533847 | Marketed | Chief Medical Supplies Ltd | Feb 2023 |
| ACID CONCENTRATE A1243 (6.86 G) | 02533758 | Marketed | Chief Medical Supplies Ltd | Jan 2023 |
| ACID CONCENTRATE A1245 (6.86 G) | 02533812 | Marketed | Chief Medical Supplies Ltd | Jan 2023 |
| ACID CONCENTRATE A1246 (6.86 G) | 02533820 | Marketed | Chief Medical Supplies Ltd | Feb 2023 |
| ACID CONCENTRATE A1252 (6.86 G) | 02533839 | Marketed | Chief Medical Supplies Ltd | Aug 2023 |
| ACID CONCENTRATE A1255 (3.48 G) | 02533766 | Marketed | Chief Medical Supplies Ltd | Aug 2023 |
| ACID CONCENTRATE A1261 (3.48 G) | 02262479 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1262 (3.48 G) | 02262487 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1263 (6.86 G) | 02533871 | Marketed | Chief Medical Supplies Ltd | Jan 2023 |
| ACID CONCENTRATE A1265 (6.86 G) | 02533863 | Marketed | Chief Medical Supplies Ltd | Aug 2023 |
| ACID CONCENTRATE A1266 (4.57 G) | 02262525 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1267 (4.57 G) | 02533898 | Marketed | Chief Medical Supplies Ltd | Jan 2023 |
| ACID CONCENTRATE A1270 (4.57 G) | 02272512 | Marketed | Chief Medical Supplies Ltd | Jan 2026 |
| ACID CONCENTRATE A1275 (3.48 G) | 02272563 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1277 (3.48 G) | 02272598 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1279 (4.57 G) | 02272628 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1294 (3.48 G) | 02268728 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1296 (4.57 G) | 02435918 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1297 (4.57 G) | 02435969 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1298 (4.57 G) | 02435950 | Marketed | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE D12201 (1.61 G) | 00860565 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12207 (2.14 G) | 00890197 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12236 (3.21 G) | 02217244 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12248 (1.61 G) | 02158329 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12262 (1.61 G) | 02158221 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12264 (2.14 G) | 02158159 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12272 (2.14 G) | 02178125 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12275 (1.61 G) | 02218879 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12286 (1.61 G) | 02217252 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12290 (1.61 G) | 02217643 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12291 (1.61 G) | 02217279 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12293 (2.14 G) | 02217554 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12294 (2.14 G) | 02217619 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12299 (3.21 G) | 02217260 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12300 (2.14 G) | 02217597 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12302 (2.14 G) | 02217635 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12305 (2.14 G) | 02217600 | Marketed | Vantive Ulc | May 2024 |
| ACID CONCENTRATE D12316 (1.61 G) | 02178168 | Marketed | Vantive Ulc | May 2024 |
| AMO ENDOSOL SOLUTION (0.03 %) | 02007967 | Marketed | Amo Canada Company | Apr 2003 |
| AVL ELECTROLYTE CONCENTRATE (0.3 G) | 02384655 | Marketed | Alberta Veterinary Laboratories Ltd | Mar 2014 |
| BALANCE 1.5% GLUCOSE, 1.25 MMOL/L CALCIUM (0.1017 G) | 02261057 | Marketed | Fresenius Medical Care Canada Inc | Apr 2021 |
| BALANCE 2.3% GLUCOSE, 1.25 MMOL/L CALCIUM (0.1017 G) | 02261073 | Marketed | Fresenius Medical Care Canada Inc | Apr 2021 |
| BALANCE 4.25% GLUCOSE, 1.25 MMOL/L CALCIUM (0.1017 G) | 02261065 | Marketed | Fresenius Medical Care Canada Inc | May 2021 |
| BSS PLUS (0.02 %) | 00568082 | Marketed | Alcon Canada Inc. | Dec 1982 |
| BSS STERILE IRRIGATING SOLUTION (0.03 %) | 00512990 | Marketed | Alcon Canada Inc. | Nov 2008 |
| CLINIMIX E (24 MG) | 02014076 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX E (24 MG) | 02013967 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX E (24 MG) | 02142384 | Marketed | Baxter Corporation | Nov 2013 |
| CLINIMIX E (24 MG) | 02498413 | Marketed | Baxter Corporation | Oct 2021 |
| CLINIMIX E (24 MG) | 02498421 | Marketed | Baxter Corporation | Dec 2020 |
| DIANEAL PD101 CAPD SOLUTION WITH 0.5% DEXTROSE (15.2 MG) | 00799793 | Marketed | Vantive Ulc | Apr 2024 |
| DIANEAL PD101 CAPD SOLUTION WITH 1.5% DEXTROSE (15.2 MG) | 00799815 | Marketed | Vantive Ulc | Apr 2024 |
| DIANEAL PD101 CAPD SOLUTION WITH 2.5% DEXTROSE (15.2 MG) | 00799823 | Marketed | Vantive Ulc | Apr 2024 |
| DIANEAL PD101 CAPD SOLUTION WITH 4.25% DEXTROSE (15.2 MG) | 00799807 | Marketed | Vantive Ulc | Apr 2024 |
| DIANEAL PD4 CAPD SOLUTION WITH 1.5% DEXTROSE AND 2.5MEQ/L CALCIUM (5.08 MG) | 00865095 | Marketed | Vantive Ulc | Apr 2024 |
| DIANEAL PD4 CAPD SOLUTION WITH 2.5% DEXTROSE AND 2.5MEQ/L CALCIUM (5.08 MG) | 00865109 | Marketed | Vantive Ulc | Apr 2024 |
| DIANEAL PD4 CAPD SOLUTION WITH 4.25% DEXTROSE AND 2.5MEQ/L CALCIUM (5.08 MG) | 00865117 | Marketed | Vantive Ulc | Apr 2024 |
| EXTRANEAL (51 MG) | 02240806 | Marketed | Vantive Ulc | Apr 2024 |
| HEMOSATE ULTRA HS1125 (2.14 G) | 02413892 | Marketed | Chief Medical Supplies Ltd | Jan 2021 |
| HEMOSATE ULTRA HS2125 (2.14 G) | 02413906 | Marketed | Chief Medical Supplies Ltd | Jan 2021 |
| HEMOSATE ULTRA HS3125 (2.14 G) | 02413914 | Marketed | Chief Medical Supplies Ltd | Jan 2021 |
| HEMOSATE ULTRA HS4125 (2.14 G) | 02413922 | Marketed | Chief Medical Supplies Ltd | Jan 2021 |
| ISOLYTE S (MULTI-ELECTROLYTE INJECTION) (30 MG) | 01931628 | Marketed | B. Braun Medical AG | Jun 1998 |
| ISOLYTE S PH 7.4 (MULTI-ELECTROLYTE INJECTION) (30 MG) | 01931679 | Marketed | B. Braun Medical AG | Jun 1998 |
| MAGNESIUM CHLORIDE FOR HEMODIALYSIS 5.15 (5.15 G) | 02528193 | Marketed | Chief Medical Supplies Ltd | Feb 2023 |
| MAGNESIUM-45 0.5-4.5 (20.5 G) | 02219301 | Marketed | Vantive Ulc | Apr 2024 |
| NATURALYTE H-200 (3.43 G) | 02330172 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Oct 2020 |
| NATURALYTE H-201 (3.43 G) | 02330024 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Oct 2020 |
| NATURALYTE H-208 (3.43 G) | 02329980 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Nov 2020 |
| NATURALYTE H-225 (4.57 G) | 02327465 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-226 (4.57 G) | 02327406 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Sep 2020 |
| NATURALYTE H-229 (4.57 G) | 02326949 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-232 (3.43 G) | 02330253 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-260 (4.57 G) | 02327384 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Feb 2021 |
| NATURALYTE H-320 (4.57 G) | 02330229 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-330 (3.43 G) | 02327503 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-332 (6.86 G) | 02327333 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-401 (6.86 G) | 02327309 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-402 (6.86 G) | 02327422 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Sep 2020 |
| NATURALYTE H-408 (6.86 G) | 02327538 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Sep 2020 |
| NATURALYTE H-410 (4.57 G) | 02327511 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Oct 2020 |
| NATURALYTE H-616 (3.43 G) | 02327066 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Nov 2020 |
| NATURALYTE H-623 (4.57 G) | 02330016 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NATURALYTE H-624 (4.57 G) | 02330032 | Marketed | Fresenius Medical Care Renal Therapies Group, Llc | Aug 2020 |
| NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 304) (2.13 G) | 02363631 | Marketed | Nxstage Medical, Inc. | Nov 2013 |
| NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK-301) (2.13 G) | 02363615 | Marketed | Nxstage Medical, Inc. | Dec 2013 |
| NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK-302) (2.13 G) | 02363666 | Marketed | Nxstage Medical, Inc. | Jul 2013 |
| NXSTAGE PUREFLOW SOLUTION (0.102 G) | 02443279 | Marketed | Nxstage Medical, Inc. | Feb 2026 |
| NXSTAGE PUREFLOW SOLUTION (0.102 G) | 02443287 | Marketed | Nxstage Medical, Inc. | Feb 2026 |
| NXSTAGE PUREFLOW SOLUTION (0.102 G) | 02443295 | Marketed | Nxstage Medical, Inc. | Aug 2026 |
| OLIMEL 5.7% E (0.81 G) | 02352532 | Marketed | Baxter Corporation | Jan 2011 |
| OLIMEL 7.6% E (0.81 G) | 02477955 | Marketed | Baxter Corporation | Oct 2018 |
| PERIOLIMEL 2.5% E (0.45 G) | 02352494 | Marketed | Baxter Corporation | Feb 2011 |
| PHYSIONEAL 40 GLUCOSE 1.36% (0.14 G) | 02247721 | Marketed | Vantive Ulc | May 2024 |
| PHYSIONEAL 40 GLUCOSE 1.36% CLEAR-FLEX (0.068 G) | 02368730 | Marketed | Vantive Ulc | May 2024 |
| PHYSIONEAL 40 GLUCOSE 2.27% (0.14 G) | 02247722 | Marketed | Vantive Ulc | May 2024 |
| PHYSIONEAL 40 GLUCOSE 2.27% CLEAR-FLEX (0.068 G) | 02368757 | Marketed | Vantive Ulc | May 2024 |
| PHYSIONEAL 40 GLUCOSE 3.86% (0.14 G) | 02247723 | Marketed | Vantive Ulc | May 2024 |
| PHYSIONEAL 40 GLUCOSE 3.86% CLEAR-FLEX (0.068 G) | 02368749 | Marketed | Vantive Ulc | May 2024 |
| PLASMA-LYTE A INJECTION (30 MG) | 02339358 | Marketed | Baxter Corporation | Dec 2010 |
| PRISM0CAL (0.108 G) | 02274876 | Marketed | Vantive Ulc | Apr 2024 |
| PRISM0CAL B22K0/0 (3.05 G) | 02441691 | Marketed | Vantive Ulc | Apr 2024 |
| PRISMASOL 0 (2.033 G) | 02243095 | Marketed | Vantive Ulc | Apr 2024 |
| PRISMASOL 4 (2.033 G) | 02277476 | Marketed | Vantive Ulc | Apr 2024 |
| QUENCH LYTE (15.7 MG) | 02229713 | Marketed | Dominion Veterinary Laboratories Ltd. | Apr 1999 |
| SELECTBAG ONE (AX 125 G) (20.3 G) | 02414813 | Marketed | Vantive Ulc | May 2024 |
| SELECTBAG ONE (AX 150 G) (20.3 G) | 02414821 | Marketed | Vantive Ulc | May 2024 |
| SELECTBAG ONE (AX 225 G) (20.3 G) | 02414856 | Marketed | Vantive Ulc | May 2024 |
| SELECTBAG ONE (AX 250 G) (20.3 G) | 02415461 | Marketed | Vantive Ulc | May 2024 |
| SELECTBAG ONE (AX 2525 G) (20.3 G) | 02415496 | Marketed | Vantive Ulc | May 2024 |
| SELECTBAG ONE (AX 325 G) (20.3 G) | 02414902 | Marketed | Vantive Ulc | May 2024 |
| SELECTBAG ONE (AX 350 G) (20.3 G) | 02415526 | Marketed | Vantive Ulc | May 2024 |
| SELECTBAG ONE (AX 450 G) (20.3 G) | 02415488 | Marketed | Vantive Ulc | May 2024 |
| SSP+ (0.3 G) | 02492067 | Marketed | Maco Pharma | Nov 2021 |
| SSP+ (0.3 G) | 02492075 | Marketed | Maco Pharma | Dec 2022 |
| TPN ELECTROLYTES (25.4 MG) | 00590215 | Marketed | Pfizer Canada Ulc | Aug 2017 |
| VETALYTE (0.42 MG) | 02426536 | Marketed | Dmvet Inc | Oct 2014 |
| ACID CONCENTRATE A1220 (4.57 G) | 02381257 | Dormant | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1229 (6.86 G) | 02533901 | Approved | Chief Medical Supplies Ltd | Dec 2022 |
| ACID CONCENTRATE A1251 (3.48 G) | 02533790 | Approved | Chief Medical Supplies Ltd | Dec 2022 |
| ACID CONCENTRATE A1253 (3.48 G) | 02248823 | Dormant | Chief Medical Supplies Ltd | Jul 2025 |
| ACID CONCENTRATE A1264 (3.48 G) | 02262509 | Approved | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1268 (4.57 G) | 02262541 | Dormant | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1269 (4.57 G) | 02262568 | Dormant | Chief Medical Supplies Ltd | Jul 2025 |
| ACID CONCENTRATE A1271 (4.57 G) | 02272520 | Dormant | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1272 (3.48 G) | 02272539 | Dormant | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1273 (6.86 G) | 02272547 | Approved | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1274 (4.57 G) | 02272555 | Dormant | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1276 (3.48 G) | 02272571 | Approved | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1278 (4.57 G) | 02272601 | Dormant | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1280 (4.57 G) | 02272636 | Approved | Chief Medical Supplies Ltd | Jul 2023 |
| ACID CONCENTRATE A1295 (4.57 G) | 02435888 | Approved | Chief Medical Supplies Ltd | Jul 2023 |
| AVL CAL-MAG-PHOS (4.5 %) | 02402041 | Approved | Alberta Veterinary Laboratories Ltd | Feb 2013 |
| BALANCE 1.5% GLUCOSE, 1.75 MMOL/L CALCIUM (0.1017 G) | 02261022 | Approved | Fresenius Medical Care Canada Inc | Dec 2019 |
| BALANCE 2.3% GLUCOSE, 1.75 MMOL/L CALCIUM (0.1017 G) | 02261049 | Approved | Fresenius Medical Care Canada Inc | Dec 2019 |
| BALANCE 4.25% GLUCOSE, 1.75 MMOL/L CALCIUM (0.1017 G) | 02261030 | Approved | Fresenius Medical Care Canada Inc | Dec 2019 |
| BALANCED SALT SOLUTION (0.3 MG) | 02023709 | Dormant | Pharma Stulln Inc. | Sep 2019 |
| CAL MAG K SOLUTION (4.5 %) | 00468959 | Dormant | Mtc Pharmaceuticals | Jul 2018 |
| CAL MAG PHOS (STERILE INJECTION) (4.5 %) | 01941569 | Dormant | Citadel Animal Health | Jul 2023 |
| CAL-PLUS (4.5 %) | 01960873 | Dormant | Bimeda-MTC Animal Health Inc. | Jul 2023 |
| CANEAL PERITONEAL DIALYSIS SOLUTION (15.2 MG) | 02453010 | Approved | Chief Medical Supplies Ltd | Mar 2016 |
| CANEAL PERITONEAL DIALYSIS SOLUTION (15.2 MG) | 02453029 | Approved | Chief Medical Supplies Ltd | Mar 2016 |
| CANEAL PERITONEAL DIALYSIS SOLUTION (5.08 MG) | 02453037 | Approved | Chief Medical Supplies Ltd | Mar 2016 |
| CANEAL PERITONEAL DIALYSIS SOLUTION (5.08 MG) | 02453045 | Approved | Chief Medical Supplies Ltd | Mar 2016 |
| CANEAL PERITONEAL DIALYSIS SOLUTION (5.08 MG) | 02472880 | Approved | Chief Medical Supplies Ltd | Feb 2018 |
| CANEAL PERITONEAL DIALYSIS SOLUTION (15.2 MG) | 02473747 | Approved | Chief Medical Supplies Ltd | Mar 2018 |
| CITRASATE C0125 (2.14 G) | 02366533 | Dormant | Chief Medical Supplies Ltd | Jun 2021 |
| CITRASATE C10125 (2.14 G) | 02325640 | Approved | Chief Medical Supplies Ltd | Apr 2009 |
| CITRASATE C1125 (2.14 G) | 02366541 | Dormant | Chief Medical Supplies Ltd | Jun 2022 |
| CITRASATE C1150 (2.14 G) | 02366592 | Dormant | Chief Medical Supplies Ltd | Aug 2018 |
| CITRASATE C2125 (2.14 G) | 02366568 | Dormant | Chief Medical Supplies Ltd | Jun 2022 |
| CITRASATE C2150 (2.14 G) | 02366606 | Dormant | Chief Medical Supplies Ltd | Jun 2022 |
| CITRASATE C3125 (2.14 G) | 02366576 | Dormant | Chief Medical Supplies Ltd | Jun 2022 |
| CITRASATE C3150 (2.14 G) | 02366614 | Dormant | Chief Medical Supplies Ltd | Jun 2022 |
| CITRASATE C4125 (2.14 G) | 02366584 | Dormant | Chief Medical Supplies Ltd | Jun 2022 |
| DEXTROSE PLUS ELECTROLYTES (270 MG) | 00308366 | Dormant | Professional Veterinary Laboratories | Oct 2020 |
| DIALYSIS SOLUTION 35 K0 (0.136 G) | 02294753 | Dormant | Chief Medical Supplies Ltd | Sep 2020 |
| DIALYSIS SOLUTION 35 K2 (0.136 G) | 02294761 | Approved | Chief Medical Supplies Ltd | Sep 2020 |
| DIALYSIS SOLUTION 35 K4 (0.136 G) | 02294788 | Dormant | Chief Medical Supplies Ltd | Sep 2020 |
| ELECTRAS (2.81 %) | 00317128 | Dormant | Dominion Veterinary Laboratories Ltd. | Oct 2020 |
| ELECTRAS PWS (2.81 %) | 00308471 | Dormant | Professional Veterinary Laboratories | Oct 2020 |
| ELECTROLYTE INFUSION STERILE INJECTION (0.3 G) | 00715654 | Dormant | Bimeda-MTC Animal Health Inc. | Jul 2023 |
| ENTEROLYTE (11 MG) | 02031353 | Dormant | Bimeda-MTC Animal Health Inc. | Jul 2018 |
| EQUINE PERFORMANCE PWS (11.52 G) | 02010984 | Dormant | Davis And Lawrence Co. | Jul 2018 |
| H.E.L.P.BICEL (1.83 G) | 02373793 | Dormant | B. Braun Avitum Ag | Jul 2025 |
| HEMASATE ULTRA HS0125 (2.14 G) | 02422557 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS1125 (2.14 G) | 02422573 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS1150 (2.14 G) | 02422565 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS2125 (2.14 G) | 02422581 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS2150 (2.14 G) | 02422409 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS3125 (2.14 G) | 02422603 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS3150 (2.14 G) | 02422611 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMASATE ULTRA HS4125 (2.14 G) | 02422417 | Approved | Chief Medical Supplies Ltd | Mar 2014 |
| HEMOSATE ULTRA HS0125 (2.14 G) | 02413876 | Approved | Chief Medical Supplies Ltd | Jan 2021 |
| HEMOSATE ULTRA HS1150 (2.14 G) | 02413930 | Approved | Chief Medical Supplies Ltd | Jan 2021 |
| HEMOSATE ULTRA HS2150 (2.14 G) | 02413957 | Dormant | Chief Medical Supplies Ltd | Jul 2025 |
| HEMOSATE ULTRA HS3150 (2.14 G) | 02413965 | Approved | Chief Medical Supplies Ltd | Jan 2021 |
| NATURALYTE H-228 (4.57 G) | 02327104 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-230 (3.43 G) | 02330180 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-321 (4.57 G) | 02326930 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-407 (6.861 G) | 02327392 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-615 (3.43 G) | 02327473 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Feb 2021 |
| NATURALYTE H-625 (4.57 G) | 02327031 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-630 (4.57 G) | 02330040 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-631 (4.57 G) | 02327090 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NATURALYTE H-706 (4.57 G) | 02327058 | Dormant | Fresenius Medical Care Renal Therapies Group, Llc | Dec 2019 |
| NORMOSOL-R (0.014 G) | 00039500 | Dormant | Icu Medical Canada Inc | Jul 2025 |
| NORMOSOL-R & 5% DEXTROSE (0.014 G) | 00039640 | Dormant | Icu Medical Canada Inc | Nov 2017 |
| NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 303) (2.13 G) | 02363623 | Dormant | Nxstage Medical, Inc. | May 2020 |
| NXSTAGE PUREFLOW DIALYSATE CONCENTRATE (SAK 305) (2.13 G) | 02363658 | Dormant | Nxstage Medical, Inc. | May 2020 |
| ODAN BALANCED SALT SOLUTION (0.3 MG) | 00622893 | Dormant | Odan Laboratoriesltd | Jun 2017 |
| PRISMASOL 2 (2.033 G) | 02277441 | Dormant | Vantive Ulc | Apr 2024 |
| SELECTBAG ONE (AX 050 G) (20.3 G) | 02414724 | Dormant | Vantive Ulc | May 2024 |
| SELECTBAG ONE (AX 200 G) (20.3 G) | 02414848 | Dormant | Vantive Ulc | Jul 2024 |
| SELECTBAG ONE (AX 2550 G) (20.3 G) | 02415518 | Approved | Vantive Ulc | May 2024 |
| SELECTBAG ONE (AX 275 G) (20.3 G) | 02414899 | Dormant | Vantive Ulc | May 2024 |
| SUPERDEX 50% INJ (270 MG) | 00260118 | Dormant | Dominion Veterinary Laboratories Ltd. | Oct 2020 |
| TQM ACID CONCENTRATE A1280 (2.12 G) | 02464527 | Approved | Tqm Enterprises Limited | Jun 2017 |
| 2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE (25.5 MG) | 02143267 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2015 |
| 2.5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE CLINIMIX (25.5 MG) | 02013975 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2015 |
| 2.5%TRAVASOL AMINO ACID INJ.W.ELEC.W.25%DEX (25.5 MG) | 02143259 | Cancelled Post Market | Clintec Nutrition Company | Aug 1998 |
| 2.75% TRAVAS. AMINO ACID INJ.W.ELECW.25%DEX (51 MG) | 02143232 | Cancelled Post Market | Clintec Nutrition Company | Aug 1998 |
| 2.75% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 25% DEXTROSE QUICKMIX (51 MG) | 02014009 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2007 |
| 2.75% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 5% DEXTROSE QUICKMIX (51 MG) | 02013991 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2007 |
| 2.75%TRAVASOL AMINO ACID INJ.W.ELEC.W.5%DEX. (51 MG) | 02143240 | Cancelled Post Market | Clintec Nutrition Company | Aug 1999 |
| 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 10% DEXTROSE (51 MG) | 02142414 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2015 |
| 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE (51 MG) | 02142406 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2007 |
| 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE QUICKMIX (51 MG) | 02014033 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2007 |
| 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 25% DEXTROSE (51 MG) | 02142392 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2015 |
| 4.25% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 5% DEXTROSE QUICKMIX (51 MG) | 02014017 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2007 |
| 4.25%TRAVASOL AMINO ACID INJ.W.ELECW.5%DEX. (51 MG) | 02143224 | Cancelled Post Market | Clintec Nutrition Company | Aug 1999 |
| 5% TRAVASOL AMINO ACID INJECTION WITH ELECTROLYTES IN 20% DEXTROSE (51 MG) | 02142368 | Cancelled Post Market | Baxter Corporation Clintec Nutrition Division | Aug 2015 |
| A LITTLE UNDERSTANDING (30 X) | 02232047 | Cancelled Post Market | Kootenay Born Botanicals | Aug 2005 |
| ACETATE CONCENTRATE R07318 LIQ (3.558 G) | 00898287 | Cancelled Post Market | Bdh Inc. | Aug 2000 |
| ACETATE CONCENTRATE R07376 (3.558 G) | 02179075 | Cancelled Post Market | Bdh Inc. | Aug 2000 |
| ACID CONCENTRATE (R04146) (3.744 G) | 02231082 | Cancelled Post Market | Genpharm Inc. | Jul 2004 |
| ACID CONCENTRATE (R04938) (3.744 G) | 00897787 | Cancelled Post Market | Genpharm Inc. | Aug 2001 |
| ACID CONCENTRATE (R04968) (3.744 G) | 00869694 | Cancelled Post Market | Genpharm Inc. | Jul 2004 |
| ACID CONCENTRATE (R04969) (3.744 G) | 00869708 | Cancelled Post Market | Genpharm Inc. | Jul 2004 |
| ACID CONCENTRATE (R04974) (3.744 G) | 00869732 | Cancelled Post Market | Genpharm Inc. | Jul 2004 |
| ACID CONCENTRATE (R04975) (3.744 G) | 00869740 | Cancelled Post Market | Genpharm Inc. | Jul 2004 |
| ACID CONCENTRATE (R04976) (3.744 G) | 00869759 | Cancelled Post Market | Genpharm Inc. | Jul 2004 |
| ACID CONCENTRATE (R04981) (3.744 G) | 00896969 | Cancelled Post Market | Genpharm Inc. | Jul 2004 |
| ACID CONCENTRATE (R04984) (3.744 G) | 00897833 | Cancelled Post Market | Genpharm Inc. | Jul 2004 |
| ACID CONCENTRATE (RO4147) (3.744 G) | 02241924 | Cancelled Post Market | Genpharm Inc. | Jul 2004 |
| ACID CONCENTRATE (RO4148) (3.744 G) | 02241925 | Cancelled Post Market | Genpharm Inc. | Jul 2004 |
| ACID CONCENTRATE (RO9503) (2.668 G) | 00898430 | Cancelled Post Market | Genpharm Inc. | Jul 2003 |
| ACID CONCENTRATE (RZ262C) (3.43 G) | 02238182 | Cancelled Post Market | Genpharm Inc. | Jul 2004 |
| ACID CONCENTRATE (RZ271C) (6.861 G) | 02238177 | Cancelled Post Market | Genpharm Inc. | Jul 2004 |
| ACID CONCENTRATE (RZ272C) (6.861 G) | 02238178 | Cancelled Post Market | Genpharm Inc. | Jul 2004 |
| ACID CONCENTRATE (RZ274C) (6.861 G) | 02238180 | Cancelled Post Market | Genpharm Inc. | Jul 2004 |
| ACID CONCENTRATE (RZ275C) (6.861 G) | 02238181 | Cancelled Post Market | Genpharm Inc. | Jul 2004 |
| ACID CONCENTRATE 2100 (1.61 G) | 00774243 | Cancelled Post Market | Baxter Corporation | Aug 2004 |
| ACID CONCENTRATE 2101 (1.61 G) | 00774790 | Cancelled Post Market | Baxter Corporation | Aug 2004 |
| ACID CONCENTRATE 2102 (1.61 G) | 00774804 | Cancelled Post Market | Baxter Corporation | Jul 2025 |
| ACID CONCENTRATE 2105 (1.61 G) | 00774839 | Cancelled Post Market | Baxter Corporation | Aug 2004 |
| ACID CONCENTRATE 2106 (1.61 G) | 02239609 | Cancelled Post Market | Baxter Corporation | Aug 2007 |
| ACID CONCENTRATE 2109 (1.61 G) | 00774871 | Cancelled Post Market | Althin Biopharm Inc. | Aug 1998 |
| ACID CONCENTRATE 2112 (1.61 G) | 00801712 | Cancelled Post Market | Western Dialysis Supplies Ltd. | Sep 1996 |
| ACID CONCENTRATE 2113 (1.61 G) | 02210037 | Cancelled Post Market | Baxter Corporation | Aug 2002 |
| ACID CONCENTRATE 2116 (1.61 G) | 00774936 | Cancelled Post Market | Baxter Corporation | Aug 2020 |
| ACID CONCENTRATE 2117 (1.61 G) | 00774944 | Cancelled Post Market | Baxter Corporation | Aug 2020 |
| ACID CONCENTRATE 2119 (1.61 G) | 02239483 | Cancelled Post Market | Baxter Corporation | Aug 2007 |
| ACID CONCENTRATE 2120 (1.61 G) | 00774960 | Cancelled Post Market | Baxter Corporation | Dec 2018 |
| ACID CONCENTRATE 2121 (3.21 G) | 00774979 | Cancelled Post Market | Baxter Corporation | Aug 2007 |
| ACID CONCENTRATE 2122 (3.21 G) | 02237690 | Cancelled Post Market | Baxter Corporation | Aug 2004 |
| ACID CONCENTRATE 2123 (3.21 G) | 02242549 | Cancelled Post Market | Baxter Corporation | Aug 2004 |
| ACID CONCENTRATE 2125 (3.21 G) | 00770213 | Cancelled Post Market | Baxter Corporation | Dec 2018 |
| ACID CONCENTRATE 2126 (1.61 G) | 02242547 | Cancelled Post Market | Baxter Corporation | Aug 2020 |
| ACID CONCENTRATE 2128 (3.21 G) | 02239482 | Cancelled Post Market | Baxter Corporation | Aug 2007 |
| ACID CONCENTRATE 2129 (3.21 G) | 02239481 | Cancelled Post Market | Baxter Corporation | Aug 2004 |
| ACID CONCENTRATE 2131 (3.21 G) | 02239480 | Cancelled Post Market | Baxter Corporation | Aug 2007 |
| ACID CONCENTRATE 2132 (3.21 G) | 02210045 | Cancelled Post Market | Baxter Corporation | Aug 2004 |
| ACID CONCENTRATE 2135 (3.21 G) | 00771244 | Cancelled Post Market | Baxter Corporation | Nov 2024 |
| ACID CONCENTRATE 2139 (3.21 G) | 00771279 | Cancelled Post Market | Baxter Corporation | Dec 2018 |
| ACID CONCENTRATE 2147 (3.21 G) | 02239479 | Cancelled Post Market | Baxter Corporation | Aug 2007 |
| ACID CONCENTRATE 2148 (3.21 G) | 02239478 | Cancelled Post Market | Baxter Corporation | Aug 2004 |
| ACID CONCENTRATE 2151 (3.21 G) | 02239486 | Cancelled Post Market | Baxter Corporation | Aug 2020 |
| ACID CONCENTRATE 2152 (3.21 G) | 02210061 | Cancelled Post Market | Baxter Corporation | Dec 2018 |
| ACID CONCENTRATE 2155 (3.21 G) | 02239489 | Cancelled Post Market | Baxter Corporation | Aug 2004 |
| ACID CONCENTRATE 2161 (2.14 G) | 02210096 | Cancelled Post Market | Baxter Corporation | Jul 2025 |
| ACID CONCENTRATE 2162 (3.21 G) | 02209942 | Cancelled Post Market | Baxter Corporation | Aug 2004 |
| ACID CONCENTRATE 2163 (2.14 G) | 02209780 | Cancelled Post Market | Baxter Corporation | Jul 2025 |
| ACID CONCENTRATE 2165 (2.14 G) | 02210533 | Cancelled Post Market | Althin Biopharm Inc. | Aug 1997 |
| ACID CONCENTRATE 2166 (3.21 G) | 02210118 | Cancelled Post Market | Althin Biopharm Inc. | Feb 2001 |
| ACID CONCENTRATE 2168 (3.21 G) | 02210126 | Cancelled Post Market | Althin Biopharm Inc. | Feb 2001 |
| ACID CONCENTRATE 2171 (3.21 G) | 02210134 | Cancelled Post Market | Baxter Corporation | Dec 2018 |
| ACID CONCENTRATE 2175 (1.61 G) | 02210150 | Cancelled Post Market | Baxter Corporation | Aug 2002 |
| ACID CONCENTRATE 2185 (2.14 G) | 02239485 | Cancelled Post Market | Baxter Corporation | Aug 2007 |
| ACID CONCENTRATE 2186 (1.61 G) | 02209950 | Cancelled Post Market | Baxter Corporation | Jul 2005 |
| ACID CONCENTRATE 2187 (1.61 G) | 02210002 | Cancelled Post Market | Althin Biopharm Inc. | Aug 1998 |
| ACID CONCENTRATE 2189 (1.61 G) | 02210010 | Cancelled Post Market | Baxter Corporation | Aug 2007 |
| ACID CONCENTRATE 2190 (2.14 G) | 02239484 | Cancelled Post Market | Baxter Corporation | Aug 2007 |
| ACID CONCENTRATE 2195 (2.14 G) | 02209985 | Cancelled Post Market | Baxter Corporation | Jul 2005 |
| ACID CONCENTRATE 2198 (1.61 G) | 02239490 | Cancelled Post Market | Baxter Corporation | Dec 2018 |
| ACID CONCENTRATE 3186 (1.75 G) | 00883530 | Cancelled Post Market | Baxter Corporation | Aug 2002 |
| ACID CONCENTRATE 3187 (1.75 G) | 00883549 | Cancelled Post Market | Baxter Corporation | Aug 2002 |
| ACID CONCENTRATE A1228 (1.61 G) | 02254239 | Cancelled Post Market | Chief Medical Supplies Ltd | Dec 2022 |
| ACID CONCENTRATE A1229 (1.61 G) | 02262460 | Cancelled Post Market | Chief Medical Supplies Ltd | Dec 2022 |
| ACID CONCENTRATE A1231 (3.21 G) | 02254395 | Cancelled Post Market | Chief Medical Supplies Ltd | Dec 2022 |
| ACID CONCENTRATE A1241 (3.21 G) | 02254352 | Cancelled Post Market | Chief Medical Supplies Ltd | Dec 2022 |
| ACID CONCENTRATE A1242 (3.21 G) | 02254379 | Cancelled Post Market | Chief Medical Supplies Ltd | Dec 2022 |
| ACID CONCENTRATE A1243 (3.21 G) | 02254093 | Cancelled Post Market | Chief Medical Supplies Ltd | Dec 2022 |
| ACID CONCENTRATE A1245 (3.21 G) | 02254387 | Cancelled Post Market | Chief Medical Supplies Ltd | Dec 2022 |
| ACID CONCENTRATE A1246 (3.21 G) | 02254360 | Cancelled Post Market | Chief Medical Supplies Ltd | Dec 2022 |
| ACID CONCENTRATE A1251 (1.61 G) | 02254107 | Cancelled Post Market | Chief Medical Supplies Ltd | Dec 2022 |
| ACID CONCENTRATE A1252 (3.21 G) | 02254115 | Cancelled Post Market | Chief Medical Supplies Ltd | Dec 2022 |